Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-16,669
Closed -$75.3K 284
2025
Q4
$75.3K Sell
16,669
-2,548
-13% -$13.1K 0.02% 255
2025
Q3
$104K Sell
19,217
-480
-2% -$2.6K 0.03% 243
2025
Q2
$107K Buy
+19,697
New +$78.1K 0.04% 238

Baron Wealth Management's CVAC Position: Q1 2026 in Review

Baron Wealth Management sold out of CureVac (CVAC) in Q1 2026, closing a stake of 16,669 shares — an estimated $75.3K sold.

Baron Wealth Management first reported a position in CVAC in Q2 2025 and held it in 3 quarters. The position peaked at $107K in Q2 2025. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.

  • Baron Wealth Management reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
  • Baron Wealth Management sold 16,669 CureVac shares in Q1 2026, an estimated $75.3K.
  • Baron Wealth Management first reported a position in CureVac in Q2 2025 and held it in 3 quarters.
  • Baron Wealth Management's CureVac position peaked at $107K in Q2 2025.
  • 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.

Based on Baron Wealth Management's 13F filing for Q1 2026, filed 16 Apr 2026.